Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Guzik

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The American Journal of Cardiology|September 1, 1990
Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging StudyJ Nadelmann, W H Frishman, W L Ooi, et al.
Digestive Diseases and Sciences|October 13, 2007
Hepatitis B and C among veterans on a psychiatric wardJames H Tabibian, Donna A Wirshing, Joseph M Pierre, et al.
Journal of Medicinal Chemistry|October 30, 1992
Isobenzofurans as conformationally constrained miconazole analogues with improved antifungal potencyR G Lovey, A J Elliott, J J Kaminski, et al.
Journal of Medicinal Chemistry|August 1, 1989
Antiulcer agents. 4. Conformational considerations and the antiulcer activity of substituted imidazo[1,2-a]pyridines and related analoguesJ J Kaminski, C Puchalski, D M Solomon, et al.
Journal of Medicinal Chemistry|July 1, 1985
Antiulcer agents. 1. Gastric antisecretory and cytoprotective properties of substituted imidazo[1,2-a]pyridinesJ J Kaminski, J A Bristol, C Puchalski, et al.
Journal of Medicinal Chemistry|November 1, 1987
Antiulcer agents. 2. Gastric antisecretory, cytoprotective, and metabolic properties of substituted imidazo[1,2-a]pyridines and analoguesJ J Kaminski, J M Hilbert, B N Pramanik, et al.
Life Sciences|March 9, 1999
SCH 57790: a novel M2 receptor selective antagonistJ E Lachowicz, D Lowe, R A Duffy, et al.
European Journal of Pharmacology|December 1, 2001
SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animalsG J Carey, W Billard, H Binch, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 26, 2001
Muscarinic agonists and antagonists in the treatment of Alzheimer's diseaseW Greenlee, J Clader, T Asberom, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The American Journal of Cardiology|September 1, 1990
Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: The Bronx Aging StudyJ Nadelmann, W H Frishman, W L Ooi, et al.
Digestive Diseases and Sciences|October 13, 2007
Hepatitis B and C among veterans on a psychiatric wardJames H Tabibian, Donna A Wirshing, Joseph M Pierre, et al.
Journal of Medicinal Chemistry|October 30, 1992
Isobenzofurans as conformationally constrained miconazole analogues with improved antifungal potencyR G Lovey, A J Elliott, J J Kaminski, et al.
Journal of Medicinal Chemistry|August 1, 1989
Antiulcer agents. 4. Conformational considerations and the antiulcer activity of substituted imidazo[1,2-a]pyridines and related analoguesJ J Kaminski, C Puchalski, D M Solomon, et al.
Journal of Medicinal Chemistry|July 1, 1985
Antiulcer agents. 1. Gastric antisecretory and cytoprotective properties of substituted imidazo[1,2-a]pyridinesJ J Kaminski, J A Bristol, C Puchalski, et al.
Journal of Medicinal Chemistry|November 1, 1987
Antiulcer agents. 2. Gastric antisecretory, cytoprotective, and metabolic properties of substituted imidazo[1,2-a]pyridines and analoguesJ J Kaminski, J M Hilbert, B N Pramanik, et al.
Life Sciences|March 9, 1999
SCH 57790: a novel M2 receptor selective antagonistJ E Lachowicz, D Lowe, R A Duffy, et al.
European Journal of Pharmacology|December 1, 2001
SCH 57790, a selective muscarinic M(2) receptor antagonist, releases acetylcholine and produces cognitive enhancement in laboratory animalsG J Carey, W Billard, H Binch, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 26, 2001
Muscarinic agonists and antagonists in the treatment of Alzheimer's diseaseW Greenlee, J Clader, T Asberom, et al.
Pageof 2